BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called AccurinsTM, announced today the presentation of late-breaker clinical data for BIND-014, ...
Apr 4, 2012
0
0
Researchers at the University of Helsinki in collaboration with researchers from Åbo Akademi University, Finland and Huazhong University of Science and Technology, China have developed a new anti-cancer nanomedicine for ...
Sep 17, 2019
0
0
(Medical Xpress)—A cardiac hormone signaling receptor abundantly expressed both in inflamed tissues and cancers appears to recruit stem cells that form the blood vessels needed to feed tumor growth, reports a new study ...
Jun 28, 2013
0
0
Tuberculosis is one of the world's deadliest infectious disease. Worldwide, there are still about 10.4 million cases of TB and 1.7 million deaths every year.
Aug 17, 2018
0
0
Liposomes are successful drug delivery vehicles prescribed for several types of cancer but also for treatment of fungal infections or pain management. Now researchers from the Medical University of Vienna show a straightforward ...
Oct 25, 2017
0
2
Researchers at Queen's University Belfast have devised a 'magic bullet' nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive ...
May 15, 2013
0
0
New England Patriots tight end Rob Gronkowski tore both his articular cartilage and medial cartilage ligaments in a game two weeks ago after a defender's jarring hit to his leg. The current recovery period for ligament tears ...
Dec 18, 2013
0
0
